Gate Neurosciences, Inc   Report issue

For profit Phase 1
Founded: Carmel IN United States (2018)

Organization Overview

First Clinical Trial
2018
NCT04981561
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Gate Neurosciences, Inc | Ronald M Burch MD PhD